ArticleFrontiers in oncology2020

Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors.

Philipp Schubert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.